aluates Reports

$ 0.0

Automative

Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Research Report 2024

Published Date: May 2024

Report Code: QYRE-Auto-25M17087

BUY CHAPTERS

Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Research Report 2024

Code: QYRE-Auto-25M17087

Report

May 2024

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Deepwise

Lepu Medical

NeuMiva

G K Healthcare

Sense Time

United-imaging

Infervision

Shukun

Fosun Aitrox

Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market

The global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution include Deepwise, Lepu Medical, NeuMiva, G K Healthcare, Sense Time, United Imaging, Infervision, Shukun, FOSUN AITROX, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution.

The Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Report

Report Metric	Details
Report Name	Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market
Segment by Type	Public Cloud Private Cloud
Segment by Application	Hospital Clinic Imaging Center
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Deepwise, Lepu Medical, NeuMiva, G K Healthcare, Sense Time, United Imaging, Infervision, Shukun, FOSUN AITROX
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market report?

Ans: The main players in the Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market are Deepwise, Lepu Medical, NeuMiva, G K Healthcare, Sense Time, United Imaging, Infervision, Shukun, FOSUN AITROX

What are the Application segmentation covered in the Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market report?

Ans: The Applications covered in the Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market report are Hospital, Clinic, Imaging Center

What are the Type segmentation covered in the Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market report?

Ans: The Types covered in the Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market report are Public Cloud, Private Cloud

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Public Cloud

1.2.3 Private Cloud

1.3 Market by Application

1.3.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Imaging Center

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Perspective (2019-2030)

2.2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Growth Trends by Region

2.2.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Historic Market Size by Region (2019-2024)

2.2.3 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Forecasted Market Size by Region (2025-2030)

2.3 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Dynamics

2.3.1 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Industry Trends

2.3.2 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Drivers

2.3.3 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Challenges

2.3.4 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Players by Revenue

3.1.1 Global Top Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Players by Revenue (2019-2024)

3.1.2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue Market Share by Players (2019-2024)

3.2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue

3.4 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Concentration Ratio

3.4.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue in 2023

3.5 Global Key Players of Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Head office and Area Served

3.6 Global Key Players of Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution, Product and Application

3.7 Global Key Players of Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Breakdown Data by Type

4.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Historic Market Size by Type (2019-2024)

4.2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Forecasted Market Size by Type (2025-2030)

5 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Breakdown Data by Application

5.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Historic Market Size by Application (2019-2024)

5.2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size (2019-2030)

6.2 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2019-2024)

6.4 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size (2019-2030)

7.2 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2019-2024)

7.4 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size (2019-2030)

8.2 Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Region (2019-2024)

8.4 Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size (2019-2030)

9.2 Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2019-2024)

9.4 Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size (2019-2030)

10.2 Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2019-2024)

10.4 Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Deepwise

11.1.1 Deepwise Company Details

11.1.2 Deepwise Business Overview

11.1.3 Deepwise Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Introduction

11.1.4 Deepwise Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024)

11.1.5 Deepwise Recent Development

11.2 Lepu Medical

11.2.1 Lepu Medical Company Details

11.2.2 Lepu Medical Business Overview

11.2.3 Lepu Medical Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Introduction

11.2.4 Lepu Medical Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024)

11.2.5 Lepu Medical Recent Development

11.3 NeuMiva

11.3.1 NeuMiva Company Details

11.3.2 NeuMiva Business Overview

11.3.3 NeuMiva Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Introduction

11.3.4 NeuMiva Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024)

11.3.5 NeuMiva Recent Development

11.4 G K Healthcare

11.4.1 G K Healthcare Company Details

11.4.2 G K Healthcare Business Overview

11.4.3 G K Healthcare Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Introduction

11.4.4 G K Healthcare Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024)

11.4.5 G K Healthcare Recent Development

11.5 Sense Time

11.5.1 Sense Time Company Details

11.5.2 Sense Time Business Overview

11.5.3 Sense Time Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Introduction

11.5.4 Sense Time Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024)

11.5.5 Sense Time Recent Development

11.6 United Imaging

11.6.1 United Imaging Company Details

11.6.2 United Imaging Business Overview

11.6.3 United Imaging Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Introduction

11.6.4 United Imaging Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024)

11.6.5 United Imaging Recent Development

11.7 Infervision

11.7.1 Infervision Company Details

11.7.2 Infervision Business Overview

11.7.3 Infervision Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Introduction

11.7.4 Infervision Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024)

11.7.5 Infervision Recent Development

11.8 Shukun

11.8.1 Shukun Company Details

11.8.2 Shukun Business Overview

11.8.3 Shukun Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Introduction

11.8.4 Shukun Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024)

11.8.5 Shukun Recent Development

11.9 FOSUN AITROX

11.9.1 FOSUN AITROX Company Details

11.9.2 FOSUN AITROX Business Overview

11.9.3 FOSUN AITROX Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Introduction

11.9.4 FOSUN AITROX Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024)

11.9.5 FOSUN AITROX Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Deepwise

Lepu Medical

NeuMiva

G K Healthcare

Sense Time

United-imaging

Infervision

Shukun

Fosun Aitrox

List of Tables

Table 1. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Public Cloud

Table 3. Key Players of Private Cloud

Table 4. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Region (2019-2024)

Table 8. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Region (2025-2030)

Table 10. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Trends

Table 11. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Drivers

Table 12. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Challenges

Table 13. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Restraints

Table 14. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Players (2019-2024)

Table 16. Global Top Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution as of 2023)

Table 17. Ranking of Global Top Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution, Headquarters and Area Served

Table 20. Global Key Players of Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution, Product and Application

Table 21. Global Key Players of Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue Market Share by Type (2019-2024)

Table 25. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue Market Share by Type (2025-2030)

Table 27. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue Market Share by Application (2019-2024)

Table 29. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue Market Share by Application (2025-2030)

Table 31. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2025-2030) & (US$ Million)

Table 46. Deepwise Company Details

Table 47. Deepwise Business Overview

Table 48. Deepwise Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product

Table 49. Deepwise Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024) & (US$ Million)

Table 50. Deepwise Recent Development

Table 51. Lepu Medical Company Details

Table 52. Lepu Medical Business Overview

Table 53. Lepu Medical Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product

Table 54. Lepu Medical Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024) & (US$ Million)

Table 55. Lepu Medical Recent Development

Table 56. NeuMiva Company Details

Table 57. NeuMiva Business Overview

Table 58. NeuMiva Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product

Table 59. NeuMiva Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024) & (US$ Million)

Table 60. NeuMiva Recent Development

Table 61. G K Healthcare Company Details

Table 62. G K Healthcare Business Overview

Table 63. G K Healthcare Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product

Table 64. G K Healthcare Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024) & (US$ Million)

Table 65. G K Healthcare Recent Development

Table 66. Sense Time Company Details

Table 67. Sense Time Business Overview

Table 68. Sense Time Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product

Table 69. Sense Time Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024) & (US$ Million)

Table 70. Sense Time Recent Development

Table 71. United Imaging Company Details

Table 72. United Imaging Business Overview

Table 73. United Imaging Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product

Table 74. United Imaging Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024) & (US$ Million)

Table 75. United Imaging Recent Development

Table 76. Infervision Company Details

Table 77. Infervision Business Overview

Table 78. Infervision Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product

Table 79. Infervision Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024) & (US$ Million)

Table 80. Infervision Recent Development

Table 81. Shukun Company Details

Table 82. Shukun Business Overview

Table 83. Shukun Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product

Table 84. Shukun Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024) & (US$ Million)

Table 85. Shukun Recent Development

Table 86. FOSUN AITROX Company Details

Table 87. FOSUN AITROX Business Overview

Table 88. FOSUN AITROX Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product

Table 89. FOSUN AITROX Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024) & (US$ Million)

Table 90. FOSUN AITROX Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

Table 94. Authors List of This Report

List of Figures

Figure 1. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Picture

Figure 2. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Type: 2023 VS 2030

Figure 4. Public Cloud Features

Figure 5. Private Cloud Features

Figure 6. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Application (2024-2030) & (US$ Million)

Figure 7. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Application: 2023 VS 2030

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Imaging Center Case Studies

Figure 11. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Report Years Considered

Figure 12. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Region: 2023 VS 2030

Figure 15. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Players in 2023

Figure 16. Global Top Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue in 2023

Figure 18. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Country (2019-2030)

Figure 20. United States Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Country (2019-2030)

Figure 24. Germany Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Region (2019-2030)

Figure 32. China Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Country (2019-2030)

Figure 40. Mexico Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Country (2019-2030)

Figure 44. Turkey Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. UAE Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Deepwise Revenue Growth Rate in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024)

Figure 48. Lepu Medical Revenue Growth Rate in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024)

Figure 49. NeuMiva Revenue Growth Rate in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024)

Figure 50. G K Healthcare Revenue Growth Rate in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024)

Figure 51. Sense Time Revenue Growth Rate in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024)

Figure 52. United Imaging Revenue Growth Rate in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024)

Figure 53. Infervision Revenue Growth Rate in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024)

Figure 54. Shukun Revenue Growth Rate in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024)

Figure 55. FOSUN AITROX Revenue Growth Rate in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Business (2019-2024)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Cardiovascular and Cerebrovascular AI assisted Diagnosis Software Market Research Report 2024

Global Cardiac AI assisted Diagnosis Solution Market Research Report 2024

Global Cardiac AI assisted Diagnosis Market Research Report 2024

Global Cardiac AI assisted Diagnosis Software Market Research Report 2024

Global Brain AI assisted Diagnosis Solution Market Research Report 2024

Global Medical AI assisted Diagnosis Solution Market Research Report 2024

Global Brain AI assisted Diagnosis Market Research Report 2024

Global AI Cardiovascular Screening System Market Research Report 2024

Global Medical AI assisted Diagnosis Market Research Report 2024

Global Medical AI assisted Diagnosis Product Market Research Report 2024

Global Brain AI assisted Diagnosis Software Market Research Report 2024

Global Artificial Intelligence Cardiovascular Screening System Market Research Report 2024

Global Medical AI assisted Diagnosis Software Market Research Report 2024

Global Lung AI assisted Diagnosis Solution Market Research Report 2024

Global Breast AI assisted Diagnosis Solution Market Research Report 2024

Global Bone AI assisted Diagnosis Solution Market Research Report 2024

Global Ophthalmic AI assisted Diagnosis Solution Market Research Report 2024

Global Liver AI assisted Diagnosis Solution Market Research Report 2024

AI in Medical Imaging Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10A6248

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8I7059

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15Y8668

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Research Report 2024

Published Date: May 2024

Report Code: QYRE-Auto-25M17087

Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Research Report 2024

FEATURED COMPANIES

Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market

Scope of Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market report?

What are the Application segmentation covered in the Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market report?

What are the Type segmentation covered in the Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market report?

FEATURED COMPANIES

RELATED REPORTS